相关实验视频

Updated: Jun 4, 2025

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA

Published on: December 19, 2019

DNAJB4 / HLJ1 缺陷使二甲基胺诱导的肝癌发生与周围瘤STAT3激活敏感

Wei-Jia Luo¹, Wei-Lun Hsu¹, Chih-Yun Lu¹

¹Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, Taiwan.

Cell biology and toxicology

|December 31, 2024

概括

人类肝脏DnaJ-Like蛋白 (HLJ1) 缺乏通过激活IL-6/STAT3信号来加速肝癌. 恢复HLJ1可以通过降低这种途径来预防和治疗肝癌.

科学领域:

肝病学肝病学是一种肝病学.
在瘤学瘤学.
分子生物学分子生物学

背景情况:

环境毒素和基因毒素有助于肝癌的发展.
肝脏中的细胞增殖可以促进前恶性病变的进展.
人类肝脏DnaJ-Like蛋白 (DNAJB4/HLJ1) 在肝癌发生过程中的功能尚不清楚.

研究的目的:

为了研究HLJ1在基因毒素诱导的肝癌发生中的作用.
探索HLJ1在肝癌中的功能背后的分子机制.

主要方法:

在HLJ1缺乏的小鼠中进行全基因组转录组分析.
用于短期和长期致癌性研究的二甲基尼托洛胺 (DEN) 管理.
将癌细胞系移植到同基因小鼠体内.

主要成果:

缺少HLJ1会改变基因表达,激活与化学诱导的肝癌和IL-6/STAT3信号传递相关的途径.
在经过DEN处理后,HLJ1缺乏的小鼠表现出放大了STAT3和H2AX酸化.
删除HLJ1促进瘤扩散和进展,在周围瘤正常组织中观察到STAT3酸化.

结论:

HLJ1通过降低周围瘤正常细胞中STAT3信号的调节来抑制肝癌发生.
缺少HLJ1可促进肝癌的发展和进展.
提高HLJ1水平可能是预防和治疗肝癌的治疗策略.

关键词:

丹麦丹麦是一个国家.在DNAJB4中,甲基氨酸二甲基氨酸.在HLJ1中,肝细胞癌是肝细胞癌.在STAT3中,我们可以使用STAT3.

更多相关视频

The Dimethylnitrosamine Induced Liver Fibrosis Model in the Rat

The Dimethylnitrosamine Induced Liver Fibrosis Model in the Rat

Published on: June 17, 2016

Differentiation of Mouse Breast Epithelial HC11 and EpH4 Cells

Differentiation of Mouse Breast Epithelial HC11 and EpH4 Cells

Published on: February 27, 2020

相关概念视频

The JAK-STAT Signaling Pathway

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...